Bio-Rad Laboratories Inc. (BIO)
Market Closed
17 Jul, 20:00
$
304. 36
+3.38
+1.123%
$
8.01B Market Cap
- P/E Ratio
- Div Yield
287,200 Volume
11.51 Eps
$ 300.98
Previous Close 
Want to track BIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Bio-Rad Laboratories Inc. (BIO) Statistics
Valuation metrics
Market Cap 8.01B
Enterprise value 9.1B
Trailing P/E (ttm) 49.81
Forward P/E 24.99
PEG ratio -0.12
Price/Sales (ttm) 3.18
Price/Book (mrq) 1.2
Enterprise Value/Revenue 3.51
Enterprise Value/EBITDA 19.37
Overview
Shares outstanding 26.83M
Float 20.9M
Shares short 34
% Held by insiders 0.16%
% Held by institutions 0.9%
Average volume (10 days) 238.3K
Average volume (90 days) 421.7K
Price summary
52-Week low 236.73
52-Week high 343.12
Beta 1.06
50-Day moving average 293.24
200-Day moving average 285.08
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio 0.2
Dividend Date -
Ex-Dividend Date -
Last split factor 2:1
Last split Date 8 Mar 2002
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.07%
Operating margin 0.09%
Operational effectiveness
Return on assets 0.02%
Return on equity 0.02%
Income Statement
Revenue (ttm) 2.59B
Revenue per share (ttm) 96.07
Quarterly revenue growth (yoy) 0.01%
Gross profit (ttm) 1.35B
EBITDA 478.9M
Net income to common (ttm) 168.8M
Diluted EPS (ttm) 6.26
Quarterly earnings growth (yoy) 0.01%
Balance Sheet
Total cash (mrq) 1.56B
Total cash per share (mrq) 58.04
Total debt (mrq) 1.38B
Total Debt/Equity (mrq) 0.2
Current ratio (mrq) 3.21%
Book value per share (mrq) 254.15
Cash Flow
Cash flow statement 510.4M
Levered free cash flow (LFCF) 229.76M
